Blar i HV - Institutt for naturvitenskapelige helsefag på tidsskrift "Acta Oncologica"
Viser treff 1-2 av 2
-
Myelosuppression in patients treated with 177Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable
(Acta Oncologica;Volume 60, 2021 - Issue 11, Peer reviewed; Journal article, 2021-08-23)Background: The aim of this study was to investigate dosimetry data and clinical variables to predict hematological toxicity in non-Hodgkin lymphoma (NHL) patients treated with [177Lutetium]Lu-liloto-mab satetraxetan. Material ... -
Terminal digit preference: a source of measurement error in breast cancer diameter reporting
(Acta Oncologica;Published online 30 Sep 2019, Journal article; Peer reviewed, 2019-09-14)Objectives: Women diagnosed with breast cancer are offered treatment and therapy based on tumor characteristics, including tumor diameter. There is scarce knowledge whether tumor diameter is accurately reported, or whether ...